Revenues of Dell Technologies (DVMT) increased sharply in the second quarter amidst aggressive efforts to take the company public again. The PC maker also revised up its guidance for fiscal 2019 to reflect the overall improvement in operations.
The company reported adjusted net income of $1.35 billion for the three-month period, higher by 21% compared to last year. On an unadjusted basis, it posted a net loss of $499 million, marking an improvement from the $732-million loss recorded in the second quarter of 2018.
At $22.9 billion, revenues were up 18% compared to the prior-year quarter, with all business segments registering double-digit growth.
“Looking toward the second half of fiscal 2019, we’ll balance this growth by executing across strategic areas of the business, including driving additional share gains, continuing to generate strong cash flow and addressing our customers’ needs with our full range of capabilities,” said Dell CFO Tom Sweet.
The PC maker also revised up its guidance for fiscal 2019 to reflect the overall improvement in operations
Encouraged by the improved results, the company raised its full-year 2019 outlook for adjusted net income to the range of $4.9 billion to $5.3 billion from the earlier guidance issued on July 2. The guidance for adjusted operating income was revised up to $8.4-$8.8 billion and the revenue forecast to the range of $90.5 billion to $92.0 billion.
Last month, Dell decided to sell the technology and technical team of Dell EMC Service Assurance Suite to IT company VMware (VMW), in which it owns a majority stake. As per the deal, Dell EMC customers will continue to have access to the solutions offered by Dell EMC Service Assurance Suite.
After taking Dell private around five years ago, CEO Michael Dell is now actively seeking shareholder support to go public again, most probably without an IPO.
Shares of Dell reached a record high last year after making strong grains over recent months. The stock, which advanced more than 16% since the beginning of the year, closed the last trading session slightly lower.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on